|
Related Links:
EXPOSURE? HEPATITIS/HIV - ENDOSCOPY CENTER SOUTHERN NEVADA
Article in the Las Vegas Review Journal about feared exposure to hepatitis and HIV
Nancy Grace Interview with InjuryBoard Member Peter Wetherall
VYTORIN/ZETIA: Complaint Filed - Press Release
COMPLETE MOISTUREPLUS CONTACT LENS SOLUTION
GADOLINIUM
TEQUIN
KETEK
New Study on Heartburn Drugs
Defective Drugs
Every year, thousands of people die or are seriously injured from adverse reactions to prescription and over-the-counter drugs. The attorneys at White & Wetherall have achieved national recognition for the verdicts and settlements they've obtained representing injured clients against irresponsible drug manufacturers. We have filed lawsuits against the makers of Fen-Phen, Vioxx, Baycol, Ephedra, Hormone Replacement Therapy and many others.
In Nevada and most other jurisdictions, drug manufacturers are 100% responsible for the safety of the drugs they make, market and distribute. Drug manufacturers are required to provide clear warnings of the risks their drugs pose to the user. When a drug manufacturer makes an unsafe product or fails to provide adequate warnings, it must pay damages to those it has injured, or to the families of those it has killed.
If you or someone you love has been harmed by a medication, it is important that you seek out attorneys who have experience in this area. If the drug is already the subject of a class action or other type of mass tort lawsuit, there will be special procedural rules in place. It is important to have attorneys who are familiar with these special procedures. Please contact us for further information.
TOP
COMPLETE MOISTUREPLUS CONTACT LENS SOLUTION
On May 26, 2007, Advanced Medical Optics issued a recall of its solution over reports of a rare eye infection due to amoeba, known as Acanthamoeba Keratitis, which can lead to vision impairment and blindness.
TOP
GADOLINIUM
Gadolinium-based dyes, which are commonly used to enhance magnetic resonance imaging (MRI) test results, have been linked to a debilitating disease known as nephrogenic systemic fibrosis (NSF).
TOP
TEQUIN
This antibiotic is in the quinolone family and was recalled by Bristol-Meyers Squibb last year due to it causing diabetes and other disturbances in the glycemic balance.
TOP
KETEK
If you or a loved one were prescribed an antibiotic medicine named Ketek (or telithromycin) for sinusitis, bronchitis, or pneumonia, and suffered serious injury or death from liver problems thereafter, please contact us and we’d be happy to provide a free evaluation of your potential case.
TOP
New Study on Heartburn Drugs
Recently, a British study reported a significantly higher risk of hip fractures in patients over 50 years of age, taking popular heartburn drugs, such as Nexium, Prevacid, or Prilosec, for more than a year. The drugs, as any television watcher or magazine reader knows, have been heavily advertised. The drugs that showed the highest risk of hip fracture in older individuals are members of a class of drugs known as proton pump inhibitors. Other popular anti-heartburn drugs, in the H-2 blocker class, such as Tagamet and Pepcid, also appeared to increase the risk of hip fracture, but not as dramatically as the proton pump inhibitors.
Several points must be kept in mind. The study is a single study only and must be replicated before governments or the pharmaceutical industry are likely to take any action with regard to the drugs. While the study spoke of an increased risk of hip fracture in anti-heart burn pill takers over 50 years old, the average age of the person in the study, was 77 years of age. It is too early to say whether there were other factors, not controlled for, that may have influenced the results.
Whatever the limitations of the study, the results were alarming. Patients amongst the 145,000 whose records were studied, who took the drugs for more than a year showed increases in their hip fracture risk ranging from 44% to as much as 2 1/2 times as great as those who did not take the drugs. It appeared that the longer the drugs were taken, the higher the hip fracture risk.
Nexium alone had global sales in 2005 of $5.7 billion. The study implicitly raises the question of whether drug companies will exercise due caution and patience in seeking approval for their drugs, when billions of dollars are at stake in the highly competitive pharmaceutical industry. Drug-related injuries affect millions of Americans each year. Pharmaceutical company cover-ups can cause tragedies. Sooner or later, older patients who suffer devastating hip fractures after taking anti-heart burn drugs for a lengthy period of time, will bring claims against the manufacturers, and attempt to find out if the drug companies knew of the hip fracture risk, and if so, what they knew and when they knew it.
TOP
Defective Medical Devices
Everyone trusts that the manufacturers of medical products like pacemakers, defibrillators, heart valves, knee replacements and arterial stents, make their products safe for our bodies. In most cases, medical products perform as expected and last for the rest of our lives. Unfortunately, in some cases, these products malfunction, break or erode, resulting in serious injury or death to the patient.
White & Wetherall believes that the makers of dangerous and defective medical products should be held accountable for their negligent and sometimes wilful behavior. We have a national reputation for our work involving implantable medical devices. If you or a loved one has been injured as a result of a defective medical device, please contact us.
Your ability to recover damages and the amount of your recovery will depend in large part on the strength and reputation of the law firm you select to handle your case.
TOP
Related Links:
JOHNSON & JOHNSON CYPHER STENT QUICK FACTS DISCUSSION BOARD
Johnson Johnson Cyper Stent
Blood clotting (thrombosis) associated with drug coated heart stents like
Johnson & Johnson's Cypher Stent, is four to five times more likely than
with regular metal stents, according to a Cleveland Clinic study released
November 29, 2006.
If you are a patient with drug-eluting stents, you should contact us at
White & Wetherall today to learn about your options and the available
legal remedies. Call us for a free stent case review! Late thrombosis
associated with stents following angioplasty can lead to heart attacks,
stroke and death.
The Cypher stent was approved by the DA in April 2003
and emits the drug Sirolimus, which is intended to solve the restenosis
(reclosure) problem by inhibiting the overgrowth of the endothelial cells in
the blood vessels. The belief among a few health care professionals is that
Sirolimus inhibits the creation of a protective coating that grows in the
vessel around the stent to protect against clots.
TAXUS STENT
What is the problem?
Boston Scientific is one of the biggest sellers in the medicated stent
market. Boston Scientific's Taxus stent has been linked to very serious and
life-threatening safety issues, which resulted in a recall announcement of
over 100,000 of the medical devices.
The Taxus defect resulting in the recall involved a balloon used to expand
the metal-mesh stents into place in a clogged coronary artery during
angioplasty surgery. Some cases showed that the balloon failed to properly
deflate, making it difficult to remove from the body.
The heart stent defect was linked to three deaths and dozens of serious
injuries.
|
